MIR4771-2

Across TCGA pan-cancer cohorts, MIR4771-2 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated MIR4771-2 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR4771-2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4771-2 expression acts as an unfavorable survival marker, although some lineages such as BRCA and LAML show a favorable association.

KIRC, COAD, and UCEC are the cancer types where MIR4771-2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.486	0.699	<.001	86	view →
COAD	DFS	Tertile	All	0.504	0.729	<.001	43	view →
UCEC	DFS	Tertile	All	0.781	0.903	.002	36	view →
UVM	DFS	Tertile	All	0.327	0.609	.008	30	view →
BRCA	DFS	Tertile	All	0.976	0.941	.035	27	view →
DLBC	OS	Tertile	III,IV	0.172	1.000	.014	27	view →
LGG	DFS	Tertile	All	0.208	0.418	.005	21	view →
CESC	DFS	Tertile	IV	0.053	0.529	<.001	18	view →
CHOL	OS	Quartile	III,IV	0.136	0.779	.017	9	view →
LIHC	DFS	Tertile	All	0.299	0.563	.012	9	view →
READ	DFS	Tertile	IV	0.255	0.628	.020	9	view →
HNSC	OS	Tertile	IV	0.313	0.660	.033	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

MIR4771-2–KIRC (OS)

Open the KIRC breakdown →